Mark E. Saad - 08 Jun 2026 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Reporting relationship: Director
Issuer ticker: AXSM
Reported as of: 08 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 21:49:38 UTC
Prior SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Nick Pizzie, Attorney-in-Fact

Key filing fact

Mark E. Saad filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 10 Jun 2026.

Key facts

This page summarizes Mark E. Saad's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2026, 21:49.

Change

Previous filing in this sequence was filed on 09 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001295913 Primary reporting owner

Saad Mark E

Relationship: Director
Address: C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Signature: /s/ Nick Pizzie, Attorney-in-Fact
Signature date: 10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXSM transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,429
Change %: +14%
Price
Shares after: 11,431
Date: 08 Jun 2026
Ownership: Direct
Footnotes: F1, F2

AXSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 300
Date: 08 Jun 2026
Ownership: See Footnote.
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXSM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -1,429
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,429
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant.

Footnote F2

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Footnote F3

Represents additional shares held indirectly by the Reporting Person prior to June 10, 2026, which includes shares indirectly beneficially owned by Mr. Saad as custodian for his children's UTMA accounts.